Bharat Biotech scouts international COVID-19 vaccine partners Reuters Aug 30, 2021 Covaxin, the company's home-grown COVID-19 vaccine approved for emergency use in India, is one of two shots driving the country's…
RDIF and Panacea Biotec partner to produce 100 mn doses of Sputnik V vaccine in India annually EP News Bureau Apr 5, 2021 The Russian Direct Investment Fund (RDIF) and Panacea Biotec announce cooperation to produce 100 million doses per year of…
Bayer examining if it can help CureVac with COVID-19 vaccine production: CEO Reuters Jan 17, 2021 CureVac's COVID-19 vaccine candidate is in late-stage clinical trials and has not yet been approved
